Press Release and Industry News
| Octapharma Announces octagam® 5% Again Available for U.S. Purchase
|
| Immune System Therapy Completes International Market Return After 2010 Voluntary Withdrawal
|
| November 30, 2011 - Hoboken NJ, /PRNewswire
- Octapharma USA announced that octagam® [Immune Globulin Intravenous (human) 5% Liquid Preparation] is again available for purchase. The U.S. Food and Drug Administration (FDA) on Nov. 3 approved the U.S. market return of octagam® 5%, a therapy to treat disorders of the immune system.
Read
More
|
|
| |
| |
| |
| |
| |
| |
|